Free Trial

Orchestra BioMed (OBIO) Institutional Ownership

Orchestra BioMed logo
$4.70 +0.01 (+0.21%)
(As of 05:19 PM ET)

Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)

Current
Institutional Ownership
Percentage
53.55%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$14.75M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$452.98K
Get OBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

OBIO Institutional Buying and Selling by Quarter

Orchestra BioMed Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2024 SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032%
11/19/2024 Barclays PLC31,785$163K0.0%+281.3%0.084%
11/16/2024 Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492%
11/15/2024 Barclays PLC31,785$163K0.0%+281.3%0.084%
11/15/2024 Jane Street Group LLC19,070$98K0.0%-19.8%0.050%
11/15/2024 State Street Corp429,613$2.21M0.0%+12.4%1.130%
11/15/2024 RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587%
11/13/2024 The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088%
11/12/2024 Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574%
11/1/2024 ABLE Financial Group LLC13,402$69K0.0%N/A0.035%
10/3/2024 SG Americas Securities LLC10,143$52K0.0%N/A0.028%
8/16/2024 SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056%
8/15/2024 The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118%
8/1/2024 Rhumbline Advisers26,439$215K0.0%+192.7%0.074%
7/26/2024 Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197%
5/15/2024 Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596%
5/11/2024 Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062%
2/1/2024 New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010%
10/27/2023 Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014%
10/27/2023 TD Asset Management Inc92,678$808K0.0%+100.0%0.259%
10/24/2023 Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113%
10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009%
10/13/2023 Arkadios Wealth Advisors51,595$450K0.0%N/A0.144%
8/24/2023 Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744%
8/11/2023 Atika Capital Management LLC64,651$453K0.0%N/A0.181%
5/16/2023 Boxer Capital LLC250,000$4.89M0.2%N/A2.230%
5/15/2023 RTW Investments LP5,118,507$100.17M2.1%N/A45.652%
4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027%
(Data available from 1/1/2016 forward)

OBIO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OBIO shares?

During the previous two years, 23 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), Boxer Capital LLC ($4.89M), Price T Rowe Associates Inc. MD ($3.01M), Geode Capital Management LLC ($2.92M), State Street Corp ($2.21M), and Charles Schwab Investment Management Inc. ($1.12M).Learn more on OBIO's institutional investors.

What percentage of Orchestra BioMed stock is owned by institutional investors?

53.55% of Orchestra BioMed stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings.

Which institutional investors have been buying Orchestra BioMed stock?

Of the 19 institutional investors that purchased Orchestra BioMed stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($7.70M), Boxer Capital LLC ($250K), Bank of New York Mellon Corp ($65.25K), Atika Capital Management LLC ($64.65K), Arkadios Wealth Advisors ($51.60K), State Street Corp ($47.31K), and Barclays PLC ($46.90K).

How much institutional buying is happening at Orchestra BioMed?

Institutional investors have bought a total of 8,392,674 shares in the last 24 months. This purchase volume represents approximately $121.49M in transactions.

Which Orchestra BioMed major shareholders have been selling company stock?

The following institutional investors have sold Orchestra BioMed stock in the last 24 months: Perceptive Advisors LLC ($225.36K), Price T Rowe Associates Inc. MD ($51.53K), The Manufacturers Life Insurance Company ($8.78K), New York State Common Retirement Fund ($7.93K), SkyView Investment Advisors LLC ($7.72K), and Jane Street Group LLC ($4.71K).

How much institutional selling is happening at Orchestra BioMed?

Institutional investors have sold a total of 306,027 shares in the last 24 months. This volume of shares sold represents approximately $2.03M in transactions.



This page (NASDAQ:OBIO) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners